Filing Details

Accession Number:
0001179110-18-013082
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-11-21 16:22:59
Reporting Period:
2018-11-20
Accepted Time:
2018-11-21 16:22:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1235010 Momenta Pharmaceuticals Inc MNTA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1229450 A Craig Wheeler C/O Momenta Pharmaceuticals, Inc.
301 Binney Street
Cambridge MA 02142
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-11-20 1,969 $12.38 180,393 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 364,402 Indirect Craig Wheeler Revocable Trust
Common Stock 36,725 Indirect Craig A Wheeler 2016 Annuity Trust
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person September 10, 2015.
  2. This transaction was executed in multiple trades at prices ranging from $12.11 to $12.60. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.